|
Extramural Support
|
RMS2014 [E]
|
$298,831,922
|
$94,835
|
N/A
|
National Institutes of Health
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
1U10CA180884-01
|
$400,000
|
$160,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
1U10CA180886-01
|
$26,616,497
|
$3,726,310
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S1
|
$79,593
|
$11,143
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S2
|
$208,457
|
$29,184
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S3
|
$229,232
|
$32,092
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S4
|
$1,163,256
|
$162,856
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S5
|
$1,543,656
|
$216,112
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S6
|
$265,465
|
$37,166
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S7
|
$3,000,000
|
$420,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
1U10CA180791-01
|
$737,200
|
$14,744
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
2P30CA138313-06
|
$1,495,000
|
$14,950
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
1R01CA183811-01A1
|
$427,850
|
$427,850
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
Consolidated Basic Cancer Research Program
|
2P30CA010815-45
|
$2,516,380
|
$150,983
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-45S1
|
$92,630
|
$5,558
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
A novel functional genomic pipeline for target identification in sarcoma
|
1R21CA187516-01
|
$211,451
|
$211,451
|
AMATRUDA, JAMES
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Role of IGF-IR tyrosine kinase in NPM-ALK-expressing T-cell lymphoma
|
5R01CA151533-04
|
$318,015
|
$79,504
|
AMIN, HESHAM
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Angiogenin-induced RNA cleavage in cancer
|
5R01CA168872-02
|
$346,327
|
$173,164
|
ANDERSON, PAUL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
1U10CA180828-01
|
$656,150
|
$32,808
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Molecular Oncology of Pediatric, Adolescent and Young Adult Sarcomas
|
ZIA BC 011493
|
$165,052
|
$165,052
|
Arnaldez, Fernanda
|
CCR (NCI)
|
|
Development of Therapeutic Approaches for Wild-Type GIST
|
ZIA BC 011494
|
$55,017
|
$27,509
|
Arnaldez, Fernanda
|
CCR (NCI)
|
|
Manipulation of kinase signaling by the human oncovirus KSHV
|
1F31CA183250-01
|
$35,431
|
$17,716
|
AVEY, DENIS
|
FLORIDA STATE UNIVERSITY
|
|
Studies of amplification in rhabdomyosarcoma
|
ZIA BC 011378
|
$286,468
|
$286,468
|
Barr, Frederic
|
CCR (NCI)
|
|
Studies of gene fusions in rhabdomyosarcoma
|
ZIA BC 011387
|
$315,115
|
$315,115
|
Barr, Frederic
|
CCR (NCI)
|
|
Epigenetic studies in rhabdomyosarcoma
|
ZIA BC 011423
|
$353,311
|
$353,311
|
Barr, Frederic
|
CCR (NCI)
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
1U10CA180833-01
|
$1,548,433
|
$77,422
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA042014-25S1
|
$75,000
|
$6,000
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-25S2
|
$33,333
|
$2,666
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-25S3
|
$148,179
|
$11,855
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-25
|
$1,505,000
|
$120,400
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Genome instability and epigenetic deregulation in retinoblastoma and osteosarcoma
|
5K99CA178207-02
|
$102,574
|
$51,287
|
BENAVENTE ARIAS, CLAUDIA
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Biological Implications and Translational Applications of HDMX Inhibition
|
ZIA BC 011261
|
$48,625
|
$19,450
|
Bernal, Federico
|
CCR (NCI)
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
ZIA SC 004020
|
$2,416,689
|
$120,834
|
Berzofsky, Jay
|
CCR (NCI)
|
|
A mouse model for human gastrointestinal stromal tumor
|
5R01CA102774-10
|
$363,278
|
$363,278
|
BESMER, PETER
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$238,328
|
$23,833
|
Beutler, John
|
CCR (NCI)
|
|
JHU ICMIC Program
|
5P50CA103175-09
|
$1,453,060
|
$174,367
|
BHUJWALLA, ZAVER
|
JOHNS HOPKINS UNIVERSITY
|
|
Improving etoposide treatment of Ewing's sarcoma
|
5R01CA152063-04
|
$300,377
|
$300,377
|
BISHOP, ALEXANDER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
Innate anti-tumor immune responses
|
3R01CA157885-04S1
|
$48,582
|
$14,575
|
BUI, JACK
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Innate anti-tumor immune responses
|
3R01CA157885-04S2
|
$62,209
|
$18,663
|
BUI, JACK
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Innate anti-tumor immune responses
|
5R01CA157885-04
|
$302,862
|
$90,859
|
BUI, JACK
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
|
ZIA BC 007363
|
$257,878
|
$128,939
|
Burke, Terrence
|
CCR (NCI)
|
|
Effects of Photodynamic Therapy on Tumor Oxygenation and Blood Flow
|
2R01CA085831-11A1
|
$324,000
|
$81,000
|
BUSCH, THERESA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Investigation of Protein-Protein Interactions in the ERAD Ubiquitylation Pathway
|
ZIA BC 011131
|
$620,955
|
$248,382
|
Byrd, R. Andrew
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA016058-38S1
|
$75,000
|
$750
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-38S2
|
$125,000
|
$1,250
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-38S3
|
$135,233
|
$1,352
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-38S4
|
$149,838
|
$1,498
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA016058-38
|
$4,444,835
|
$44,448
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Molecular Pathogenic Mechanism of Rhabdomyosarcoma
|
ZIA BC 011189
|
$9,747
|
$9,747
|
Cao, Liang
|
CCR (NCI)
|
|
Preclinical Development of Novel Targeted Therapeutics Against Pediatric Sarcoma
|
ZIC BC 011048
|
$87,721
|
$52,632
|
Cao, Liang
|
CCR (NCI)
|
Total relevant funding to Sarcoma for this search: $71,995,071
|